Technical Analysis for ROTH - Pharmaroth Labs Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
0.0009 | -10.00% | -0.0001 |
ROTH closed down 10.0 percent on Wednesday, December 11, 2019, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| See historical ROTH trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 50 DMA | Bearish | -10.00% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Sector: Healthcare
- Industry: Biotechnology
PharmaRoth Labs, Inc. is focused on diabetes prevention and treatments. The Company holds the intellectual property and all exclusive world-wide rights related to the production, marketing, and distribution of Sucanon(R), an oral treatment for Type-II diabetes. Sucanon(R) is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver's sensitivity to insulin. Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars. PharmaRoth's strategy is to increase awareness, acceptance, and distribution of Sucanon(R) globally.
Medical Specialties RTT Diabetes Organ Systems Endocrine System Diabetes Mellitus Insulin Diabetes Management Insulin Resistance Diabetes Mellitus Type 2
Medical Specialties RTT Diabetes Organ Systems Endocrine System Diabetes Mellitus Insulin Diabetes Management Insulin Resistance Diabetes Mellitus Type 2
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Date | Title |
|---|
| Indicator | Value |
|---|---|
| 52 Week High | 0.006 |
| 52 Week Low | 0.0003 |
| Average Volume | 1,054,780 |
| 200-Day Moving Average | 0.0019 |
| 50-Day Moving Average | 0.0011 |
| 20-Day Moving Average | 0.0010 |
| 10-Day Moving Average | 0.0010 |
| Average True Range | 0.0009 |
| ADX | 29.43 |
| +DI | 51.3514 |
| -DI | 9.4595 |
| Chandelier Exit (Long, 3 ATRs ) | 0.0023 |
| Chandelier Exit (Short, 3 ATRs ) | 0.0034 |
| Upper Bollinger Band | 0.0013 |
| Lower Bollinger Band | 0.0007 |
| Percent B (%b) | 0.33 |
| BandWidth | 60.0000 |
| MACD Line | -0.0002 |
| MACD Signal Line | -0.0001 |
| MACD Histogram | -0.0001 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.0012 | ||||
| Resistance 3 (R3) | 0.0012 | 0.0012 | 0.0012 | ||
| Resistance 2 (R2) | 0.0012 | 0.0011 | 0.0012 | 0.0011 | |
| Resistance 1 (R1) | 0.0010 | 0.0010 | 0.0010 | 0.0010 | 0.0011 |
| Pivot Point | 0.0010 | 0.0010 | 0.0010 | 0.0010 | 0.0010 |
| Support 1 (S1) | 0.0008 | 0.0009 | 0.0008 | 0.0008 | 0.0007 |
| Support 2 (S2) | 0.0008 | 0.0008 | 0.0008 | 0.0007 | |
| Support 3 (S3) | 0.0006 | 0.0008 | 0.0007 | ||
| Support 4 (S4) | 0.0006 |
